Roche, Stephanie D.
Were, Daniel
Crawford, Natalie D.
Tembo, Angela
Pintye, Jillian
Bukusi, Elizabeth
Ngure, Kenneth
Ortblad, Katrina F.
Article History
Accepted: 28 February 2024
First Online: 22 March 2024
Declarations
:
: EB has provided consultant scientific advisory/speakers bureau services in the past 3 years for Gilead, Merck and ViiV. KN is a current grantee under the Merck Investigator Initiated Program (MISP HIV-IISP #61171). For the remaining authors, none were declared.
: In writing this article, none of the authors conducted any studies with human or animal subjects.